1. Home
  2. VBIX vs GDTC Comparison

VBIX vs GDTC Comparison

Compare VBIX & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VBIX
  • GDTC
  • Stock Information
  • Founded
  • VBIX N/A
  • GDTC 2018
  • Country
  • VBIX Israel
  • GDTC Singapore
  • Employees
  • VBIX N/A
  • GDTC N/A
  • Industry
  • VBIX Computer Software: Prepackaged Software
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • VBIX Technology
  • GDTC Health Care
  • Exchange
  • VBIX Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • VBIX 26.4M
  • GDTC 28.0M
  • IPO Year
  • VBIX N/A
  • GDTC 2023
  • Fundamental
  • Price
  • VBIX $4.95
  • GDTC $2.14
  • Analyst Decision
  • VBIX
  • GDTC Buy
  • Analyst Count
  • VBIX 0
  • GDTC 1
  • Target Price
  • VBIX N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • VBIX 114.7K
  • GDTC 5.9K
  • Earning Date
  • VBIX 08-14-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • VBIX N/A
  • GDTC N/A
  • EPS Growth
  • VBIX N/A
  • GDTC N/A
  • EPS
  • VBIX N/A
  • GDTC N/A
  • Revenue
  • VBIX $19,672,000.00
  • GDTC $368,838.00
  • Revenue This Year
  • VBIX N/A
  • GDTC $5.37
  • Revenue Next Year
  • VBIX N/A
  • GDTC N/A
  • P/E Ratio
  • VBIX N/A
  • GDTC N/A
  • Revenue Growth
  • VBIX N/A
  • GDTC N/A
  • 52 Week Low
  • VBIX $0.18
  • GDTC $1.20
  • 52 Week High
  • VBIX $12.00
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • VBIX N/A
  • GDTC 44.67
  • Support Level
  • VBIX N/A
  • GDTC $2.08
  • Resistance Level
  • VBIX N/A
  • GDTC $2.31
  • Average True Range (ATR)
  • VBIX 0.00
  • GDTC 0.11
  • MACD
  • VBIX 0.00
  • GDTC -0.00
  • Stochastic Oscillator
  • VBIX 0.00
  • GDTC 12.18

About VBIX Viewbix Inc. Common Stock

ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: